OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breast Cancer Treatments: Updates and New Challenges
Anna Burguin, Caroline Diorio, Francine Durocher
Journal of Personalized Medicine (2021) Vol. 11, Iss. 8, pp. 808-808
Open Access | Times Cited: 273

Showing 26-50 of 273 citing articles:

Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy
Alba Amaro-da-Cruz, Teresa Rubio‐Tomás, Ana I. Álvarez‐Mercado
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 5

Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities—A State-of-the-Art Review
Dominika Kunachowicz, Karolina Kłosowska, N. Sobczak, et al.
Nanomaterials (2024) Vol. 14, Iss. 17, pp. 1424-1424
Open Access | Times Cited: 5

Black phosphorus-based nanoplatforms for cancer therapy: chemistry, design, biological and therapeutic behaviors
Ashkan Bigham, Manuel Serrano‐Ruiz, Maria Caporali, et al.
Chemical Society Reviews (2024)
Open Access | Times Cited: 5

PARP14 Contributes to the Development of the Tumor-Associated Macrophage Phenotype
Isotta Sturniolo, Csongor Váróczy, Zsolt Regdon, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3601-3601
Open Access | Times Cited: 4

Endophytic fungi: A future prospect for breast cancer therapeutics and drug development
Sherin Varghese, M. S. Jisha, Kunhiraman C. Rajeshkumar, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33995-e33995
Open Access | Times Cited: 4

Anticancer Effects of MAPK6 siRNA‐Loaded PLGA Nanoparticles in the Treatment of Breast Cancer
Ceyhun Toruntay, Fatma Şayan Poyraz, Seda Süsgün, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access

Unveiling the Therapeutic Potential: Okra-Derived Flavonoids in Breast Cancer Treatment
Anum Munir, Alan Janbey
Journal of Pharmaceutical Innovation (2025) Vol. 20, Iss. 1
Closed Access

Computational predictions of magnetic resonance acoustic radiation force imaging for breast cancer focused ultrasound therapy
C. Nelson, Meredith Kline, Allison Payne, et al.
International Journal of Hyperthermia (2025) Vol. 42, Iss. 1
Open Access

Global transcriptome profiling of ST09 treated breast cancer cells identifies miR-197-5p/GPX3 antioxidant axis as a regulator of tumorigenesis
Snehal Nirgude, Sagar Desai, Febina Ravindran, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114127-114127
Closed Access

Global epidemiological status of breast cancer burden: Potential reduction strategies and preventive measures
Riya Sharma, Shanoo Sharma, Anu Dhiman, et al.
Elsevier eBooks (2025), pp. 1-10
Closed Access

Breast cancer and its genetic heterogeneity at single cell level: A concise perspective of cellular architecture and taxonomy
Riya Sharma, Neha Parihar, Keerti Gopi, et al.
Elsevier eBooks (2025), pp. 89-112
Closed Access

Phyto-mediated fabrication of silver nanoparticles from Scrophularia striata extract (AgNPs-SSE): a potential inducer of apoptosis in breast cancer cells
Niloufar Javar, Seyed Ataollah Sadat Shandiz, Maryam Abbasi
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Lifestyle Factors and Family History of Diabetes as Significant Risks for Breast Cancer: A Hospital-Based Cohort Study in Tamil Nadu, India
Kanagaraj Suganya, S. Sumathi, Balraj Sudha, et al.
Indian Journal of Surgical Oncology (2025)
Closed Access

A review of six bioactive compounds from preclinical studies as potential breast cancer inhibitors
Shailima Rampogu, Mugahed A. Al-antari, Tae Hwan Oh, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Genetic advancements in breast cancer treatment: a review
Marzieh Shokoohi, Sadaf Sedaghatshoar, Homaira Arian, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Ethnobotanical survey of medicinal plants used in management of Breast cancers in Qatar
Rasha S.Abo El Alaa, Hend Al-Jaber, Fatima Al Zahraa Chokor, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42541-e42541
Open Access

Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models
Atziri Corin Chavez Alvarez, Chahrazed Bouzriba, Vincent Ouellette, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 233-233
Open Access

Glut-1 inhibition in breast cancer cells
Ajeesh Babu Littleflower, Sulfath Thottungal Parambil, Gisha Rose Antony, et al.
Vitamins and hormones (2025), pp. 181-211
Closed Access

Scroll to top